understanding competition in the distribution of pharmaceutical products europe an analysis application article 82 ec to supply restrictions sector september 2005 european association euro companies eaepc secretary general org www ii foreword from hans bøgh sørensen president much has been written and said since 31 may when court justice it was unable rule case syfait others vs glaxosmithkline gsk greece this be a landmark laying out rules for applying eu treaty eagerly anticipated by all parties greek commission had concerned that as dominant player market three particular medicines abusing its position restricting supplies these wholesalers always believed behaviour large multinational manufacturers limiting is not only completely illegal under law but morally questionable because risks patient health we were particularly astounded his opinion on 28
